Cargando…
P1157: PHASE II STUDY OF GLOFITAMAB, POSELTINIB AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE B CELL LYMPHOMAS
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431110/ http://dx.doi.org/10.1097/01.HS9.0000971524.36320.c6 |
| _version_ | 1785091122194808832 |
|---|---|
| author | Min Byun, Ja Yoon, Sung-Soo Hong, Junshik Shin, Dong-Yeop Koh, Youngil |
| author_facet | Min Byun, Ja Yoon, Sung-Soo Hong, Junshik Shin, Dong-Yeop Koh, Youngil |
| author_sort | Min Byun, Ja |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431110 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311102023-08-17 P1157: PHASE II STUDY OF GLOFITAMAB, POSELTINIB AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE B CELL LYMPHOMAS Min Byun, Ja Yoon, Sung-Soo Hong, Junshik Shin, Dong-Yeop Koh, Youngil Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431110/ http://dx.doi.org/10.1097/01.HS9.0000971524.36320.c6 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Min Byun, Ja Yoon, Sung-Soo Hong, Junshik Shin, Dong-Yeop Koh, Youngil P1157: PHASE II STUDY OF GLOFITAMAB, POSELTINIB AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE B CELL LYMPHOMAS |
| title | P1157: PHASE II STUDY OF GLOFITAMAB, POSELTINIB AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE B CELL LYMPHOMAS |
| title_full | P1157: PHASE II STUDY OF GLOFITAMAB, POSELTINIB AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE B CELL LYMPHOMAS |
| title_fullStr | P1157: PHASE II STUDY OF GLOFITAMAB, POSELTINIB AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE B CELL LYMPHOMAS |
| title_full_unstemmed | P1157: PHASE II STUDY OF GLOFITAMAB, POSELTINIB AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE B CELL LYMPHOMAS |
| title_short | P1157: PHASE II STUDY OF GLOFITAMAB, POSELTINIB AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE B CELL LYMPHOMAS |
| title_sort | p1157: phase ii study of glofitamab, poseltinib and lenalidomide in patients with relapsed/refractory diffuse b cell lymphomas |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431110/ http://dx.doi.org/10.1097/01.HS9.0000971524.36320.c6 |
| work_keys_str_mv | AT minbyunja p1157phaseiistudyofglofitamabposeltinibandlenalidomideinpatientswithrelapsedrefractorydiffusebcelllymphomas AT yoonsungsoo p1157phaseiistudyofglofitamabposeltinibandlenalidomideinpatientswithrelapsedrefractorydiffusebcelllymphomas AT hongjunshik p1157phaseiistudyofglofitamabposeltinibandlenalidomideinpatientswithrelapsedrefractorydiffusebcelllymphomas AT shindongyeop p1157phaseiistudyofglofitamabposeltinibandlenalidomideinpatientswithrelapsedrefractorydiffusebcelllymphomas AT kohyoungil p1157phaseiistudyofglofitamabposeltinibandlenalidomideinpatientswithrelapsedrefractorydiffusebcelllymphomas |